Skip to main content
Clinical Trials/ISRCTN10850448
ISRCTN10850448Completed未知

Effective use of an SMS real time monitoring platform on Indonesia's National Measles and Rubella Immunization Campaign: a mixed methods evaluation of RapidPro

Gavi, The Vaccine Alliance0 sites81 target enrollmentStarted: September 17, 2018Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
81

Study Overview

Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33303436/ results (added 11/01/2021)

Study Design

Study Type
Observational

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Participants should be any of the following:
  • 1. Central level: Immunisation program managers at MoH, UNICEF, and WHO
  • 2. Province level: Immunisation program managers at Province Health Offices
  • 3. District level: Immunisation program managers at District Health Offices
  • 4. Sub-district level: Immunisation coordinators at community health center (Pusat Kesehatan Masyarakat)

Exclusion Criteria

  • 1. Stakeholders who are not entering and/or receiving RapidPro data
  • 2. Stakeholders who are not stationed at selected study sites
  • 3. Stakeholders who decline to participate on study.

Investigators

Sponsor
Gavi, The Vaccine Alliance

Similar Trials